Prostatic Neoplasms Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Birmingham, Alabama
  • +390 more
2021-10-14
Oct 14, 2021
A
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Available
  • Prostatic Neoplasms
  • Florianopolis, Brazil
  • +19 more
2021-10-14
Oct 14, 2021
J
A Study of Participants With Advanced Prostate Cancer in Canada
Active, not recruiting
  • Prostatic Neoplasms
  • Standard of Care
  • Calgary, Alberta, Canada
  • +21 more
2021-10-14
Oct 14, 2021
N
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Recruiting
  • Prostatic Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-10-14
Oct 14, 2021
N
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Recruiting
  • Prostatic Neoplasms
  • Prostate Cancer
  • Nimes Cedex 9, France
  • +3 more
2021-10-13
Oct 13, 2021
J
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Recruiting
  • Prostatic Neoplasms
  • La Jolla, California
  • +224 more
2021-10-14
Oct 14, 2021
N
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC
Recruiting
  • Prostatic Neoplasms
  • Jacksonville, Florida
  • +26 more
2021-10-13
Oct 13, 2021
J
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Prostate-Specific Membrane Antigen-Positron Emission Tomography (PSMA-PET) Positive Hormone-Sensitive Prostate Cancer Participants
Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Bedford Park, Australia
  • +98 more
2021-10-14
Oct 14, 2021
J
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
Active, not recruiting
  • Prostatic Neoplasms
  • Androgen-deprivation Therapy (ADT)
  • +6 more
  • Akita, Japan
  • +76 more
2021-10-14
Oct 14, 2021
J
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
Recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +29 more
2021-10-14
Oct 14, 2021
A
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Active, not recruiting
  • Prostatic Neoplasms
  • Homewood, Alabama
  • +271 more
2021-10-14
Oct 14, 2021
J
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants
Recruiting
  • Prostatic Neoplasms
  • Duarte, California
  • +10 more
2021-10-07
Oct 7, 2021
N
177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
Recruiting
  • Prostatic Neoplasms
  • 177Lu-PSMA-617
  • +3 more
  • New Orleans, Louisiana
  • +32 more
2021-10-13
Oct 13, 2021
N
Study of Diagnostic Performance of [18F]CTT1057 in BCR
Recruiting
  • Prostatic Neoplasms
  • +2 more
  • Marseille Cedex 05, France
  • +2 more
2021-10-11
Oct 11, 2021
B
Treatment Satisfaction With Ra-223 in Japan
Recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
2021-10-09
Oct 9, 2021
U
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer - 2020
Terminated
Has Results
  • Prostatic Neoplasms
  • Pelvic Nodal
  • San Francisco, California
    University of California San Francisco
2021-09-14
Sep 14, 2021
M
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
Recruiting
  • Prostatic Neoplasms
  • Pembrolizumab
  • +2 more
  • Mobile, Alabama
  • +239 more
2021-10-08
Oct 8, 2021
N
Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
Active, not recruiting
  • Prostatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-10-08
    Oct 8, 2021
    J
    A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
    Active, not recruiting
    • Prostatic Neoplasms
    • Beijing, China
    • +3 more
    2021-10-07
    Oct 7, 2021
    J
    A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer
    Recruiting
    • Prostatic Neoplasms
    • New York, New York
    • +9 more
    2021-10-07
    Oct 7, 2021
    J
    A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
    Recruiting
    • Prostatic Neoplasms
    • Adenocarcinoma
    • Duarte, California
    • +6 more
    2021-10-07
    Oct 7, 2021
    J
    A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
    Recruiting
    • Prostatic Neoplasms
    • West Valley City, Utah
    • +20 more
    2021-10-07
    Oct 7, 2021
    J
    A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
    Recruiting
    • Prostatic Neoplasms
    • Tucson, Arizona
    • +31 more
    2021-10-07
    Oct 7, 2021
    J
    An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
    Active, not recruiting
    • Prostatic Neoplasms
    • Tucson, Arizona
    • +109 more
    2021-10-07
    Oct 7, 2021
    A
    A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    2021-10-07
    Oct 7, 2021